Status and Development Trend of Evaluation of Post-Marketing Traditional Chinese Medicines in China

• 作者: 王志飞 谢雁鸣 魏瑞丽
• 来源期刊: 世界中西医结合杂志（英文）
• 年，卷（期）: 2020,（6）
• 所属期刊栏目: PHARMACEUTICAL RESEARCH
• 页码范围: 15-22
• 页数: 8页
• 语种: 中文

摘要

Evaluation of traditional Chinese medicines after the market has achieved fruitful results after years of development. The real-world research concept has been first proposed by Chief Researcher Xie Yanming in 2010 and to 2020 with the approval of the National Medical Products Administration to use real-world evidence to support drug development and review in 2020. Real-world data application and transformation continue to cause heated discussions in the industry. Real-world research concepts have been added new motivation into the evaluation of Chinese medicines after they are marketed. The development of the Chinese patent medicine industry is facing unprecedented opportunities and challenges.